Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Research site

Medical Center Askela Innovations OOD

Bulgaria Ulitsa Geo Milev 153b, 1574 Sofia, Bulgaria

  • 3 trials recruiting
  • Cardiovascular disorder · Hypertension · Arteriosclerosis
  • Adult patients

About Specializations

Medical Center Askela Innovations OOD in Sofia, Bulgaria specialises in clinical trials of conditions such as Cardiovascular disorder, Hypertension, Arteriosclerosis, Heart failure with preserved ejection fraction, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiology

The medical center is at the forefront of cardiology research, focusing on innovative treatments for heart-related conditions. The ongoing research aims to enhance the understanding and management of cardiovascular diseases, particularly in the area of stable angina pectoris.

  • Stable Angina Pectoris
  • Anti-anginal Therapies
  • Cardiovascular Health

Through the ORESA Study, the center is dedicated to confirming the efficacy of novel therapeutic agents like T89, which are designed to alleviate symptoms and improve the quality of life for patients with chronic stable angina.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ulitsa Geo Milev 153b1574 SofiaBulgaria
Open in maps ↗
Recruiting now
3 trials
Conditions studied
5

More sites in SofiaBulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Cardiovascular disorder+1

Recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.

Arteriosclerosis

Recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB

Heart failure with preserved ejection fraction

Recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB

Angina pectoris

Not yet recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Glyceryl Trinitrate
  • Sponsor:Tasly Pharmaceuticals Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.